News
Sustained response at 2 years reported for newly approved oral psoriasis agent
- Author:
- Ted Bosworth
Long-term results with the JAK inhibitor for psoriasis show responses persist.
News
Targeted anti-IgE therapy found safe and effective for chronic urticaria
- Author:
- Ted Bosworth
Two phase 3 trials associated ligelizumab with efficacy comparable to omalizumab, an approved CSU therapy.
News
PARADISE-MI results obscured as post hoc analysis finds flaws
- Author:
- Ted Bosworth
A post hoc analysis of the PARADISE-MI trial suggests relevant benefits are being missed in current trial design.
News
Polypodium leucotomos found to reverse AK skin damage
- Author:
- Ted Bosworth
Microscopy at 12 months associated polypodium leucotomos with reversal of skin damage from actinic keratosis.
News
AI-assisted reading of echocardiograms readily detects severe aortic stenosis
- Author:
- Ted Bosworth
Moderate and severe aortic stenosis is identified accurately on echocardiograms by artificial intelligence.
News
ARBs, beta-blockers independently inhibit Marfan syndrome progression
- Author:
- Ted Bosworth
Compiled data support angiotensin receptor blockers and beta-blockers, alone or together, for Marfan syndrome.
News
New ovulatory disorder classifications from FIGO replace 50-year-old system
- Author:
- Ted Bosworth
Once an ovulatory disorder has been diagnosed, four basic categories provide a framework for classification.
News
Artificial intelligence poised to change paradigm of CV risk prevention
- Author:
- Ted Bosworth
A new generation causal-based AI algorithm promises to personalize CV risk management to prevent events.
News
In blinded trial, artificial intelligence beats sonographers for echo accuracy
- Author:
- Ted Bosworth
In a blinded trial, artificial intelligence provided a more consistent reading of echocardiograms than sonographers.
News
Secondary CV prevention benefit from polypill promises global health benefit
- Author:
- Ted Bosworth
In older patients with a prior myocardial infarction, a three-drug polypill significantly reduced risk of CV events in the multinational SECURE...
News
Second opinions on melanocytic lesions swayed when first opinion is known
- Author:
- Ted Bosworth
Downward and upward shifts in severity from an accurate diagnosis are concerning because of the likelihood they will lead to overtreatment or...
News
How nonadherence complicates cardiology, in two trials
- Author:
- Ted Bosworth
Nonadherence prevents patients from achieving treatment benefits, but it also complicates trial interpretation, suggests subanalyses of MASTER...
News
Concerns that low LDL-C alters cognitive function challenged in novel analysis
- Author:
- Ted Bosworth
A Mendelian randomization study appears to exonerate very low LDL-C but not therapies from altering cognition.
News
COVID skin manifestations vary by type of variant, U.K. study finds
- Author:
- Ted Bosworth
Omicron and Delta COVID-19 skin manifestations differ, according to large U.K. patient survey.
News
Remnant cholesterol captures residual CV risk in patients with T2D
- Author:
- Ted Bosworth
Baseline and follow-up remnant cholesterol levels predict cardiovascular events in patients with type 2 diabetes.